Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT, SPIKEVAX X Injection, SPIKEVAX JN Injection and SPIKEVAX IN PRE-FILLED SYRINGE

← catalyst calendar

NCT06333704 · readout in 953 d

Sponsored by ModernaTX, Inc. (industry) · MRNA — their whole pipeline →. With C&R Research, Inc..

Phase

—

Status

Active, not recruiting

Study type

Observational

Enrollment

4,207actual

Sites

Country

South Korea

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis

Date

Filed

Basis

What it is

Start

2023-03-10

actual

When the study began enrolling

Primary completion

2029-03-29

estimated

The date the last participant is measured for the primary outcome — the readout window

Study completion

2029-03-29

estimated

The whole study's end, after follow-up

First posted

2024-03-27

actual

When this record first appeared on the registry

Results posted

—

When the sponsor posted results to the registry

Record updated

2026-04-16

actual

The sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

SARS-CoV-2

Interventions

Biological: SPIKEVAX Bivalent BA.1 — also filed as MODERNA SPIKEVAX BIVALENT (Elasomeran, Imelasomeran), SPIKEVAX BIVALENT (Elasomeran, Imelasomeran)
Biological: SPIKEVAX Bivalent BA.4/5 — also filed as SPIKEVAX BIVALENT (Elasomeran, Davesomeran), SPIKEVAX BIVALENT INJECTION DUO (Elasomeran, Davesomeran)
Biological: SPIKEVAX XBB.1.5 — also filed as SPIKEVAX X Injection
Biological: SPIKEVAX JN.1 — also filed as SPIKEVAX JN Injection, SPIKEVAX in Pre-filled Syringe

Primary outcome

what the primary-completion date above is the date OF

Number of Participants With AEs

measured Up to 28 days post vaccination

Permalink · MRNA's whole pipeline · Catalyst calendar · Every registered study · What changed